ONC · BeOne Medicines Ltd. · Documents
$384.50
+14.33 (+3.87%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$42.11B
Shares
113.77M
Volume · Oct 20
408.37K
Avg daily vol (3M)
386.32K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-12-08 | 2020-12-06 | |
| 8-K | — | 2020-12-02 | 2020-12-01 | |
| 8-K | — | 2020-11-20 | 2020-11-19 | |
| 8-K | — | 2020-11-17 | — | |
| 8-K | — | 2020-11-16 | 2020-11-15 | |
| 8-K | — | 2020-11-09 | — | |
| 8-K | — | 2020-11-05 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| DEF 14A | — | 2020-10-09 | 2020-11-20 | |
| 8-K | — | 2020-10-06 | — | |
| 8-K | — | 2020-10-02 | 2020-09-28 | |
| 8-K | — | 2020-09-24 | — | |
| 8-K | — | 2020-09-21 | 2020-09-17 | |
| 8-K | — | 2020-09-09 | 2020-09-04 | |
| 8-K | — | 2020-08-27 | — | |
| 8-K | — | 2020-08-25 | 2020-08-24 | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-08-06 | — | |
| 8-K | — | 2020-07-21 | 2020-07-17 | |
| 8-K | — | 2020-07-13 | 2020-07-12 | |
| 8-K | — | 2020-07-10 | 2020-07-09 | |
| 8-K | — | 2020-07-02 | 2020-06-30 | |
| 8-K | — | 2020-06-24 | 2020-06-18 | |
| 8-K | — | 2020-06-17 | — | |
| 8-K | — | 2020-06-15 | 2020-06-12 | |
| 8-K | — | 2020-06-03 | — | |
| 8-K | — | 2020-06-01 | 2020-05-29 | |
| S-3ASR | — | 2020-05-11 | — | |
| 8-K | — | 2020-05-11 | — | |
| S-3ASR | — | 2020-05-11 | — | |
| 10-Q | — | 2020-05-11 | 2020-03-31 | |
| DEF 14A | — | 2020-04-28 | 2020-06-17 | |
| PRE 14A | — | 2020-04-17 | 2020-06-17 | |
| 8-K | — | 2020-04-13 | 2020-04-10 | |
| 8-K | — | 2020-03-30 | — | |
| PRE 14A | — | 2020-03-30 | 2020-05-14 | |
| 8-K | — | 2020-03-25 | — | |
| 8-K | — | 2020-03-17 | — | |
| 10-K | — | 2020-03-02 | 2019-12-31 | |
| 8-K | — | 2020-03-02 | — | |
| 8-K | — | 2020-01-24 | — | |
| 8-K | — | 2020-01-21 | — | |
| 8-K | — | 2020-01-13 | 2020-01-12 | |
| 8-K | — | 2020-01-02 | — |
Showing 201–244 of 244 filings
Key facts
CIK
1651308
CUSIP
07725L102
13F (30d)
39 filings
37 filers
Visit website
Investor relations